Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Accuray Stock Quote

Accuray (NASDAQ: ARAY)

Price as of December 5, 2023, 1:47 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Accuray Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
ARAY +28.78% -33.50% -7.83% -91%
S&P +12.71% +66.46% +10.72% +217%

Accuray Company Info

Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

News & Analysis

The Fool has written over 100 articles on Accuray.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.